Comparison of responses to ranibizumab between patients with typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
Phase of Trial: Phase IV
Latest Information Update: 20 Jun 2016
At a glance
- Drugs Ranibizumab (Primary)
- Indications Age-related macular degeneration; Choroidal neovascularisation
- Focus Therapeutic Use
- 20 Jun 2016 New trial record